Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).
Kandzari, David E
Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis). [electronic resource] - Circulation Oct 2017 - 1304-1314 p. digital
Publication Type: Journal Article; Randomized Controlled Trial
1524-4539
10.1161/CIRCULATIONAHA.117.028885 doi
Coronary Artery Disease--therapy
Drug-Eluting Stents--standards
Female
Humans
Male
Percutaneous Coronary Intervention--methods
Prospective Studies
Sirolimus--administration & dosage
Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis). [electronic resource] - Circulation Oct 2017 - 1304-1314 p. digital
Publication Type: Journal Article; Randomized Controlled Trial
1524-4539
10.1161/CIRCULATIONAHA.117.028885 doi
Coronary Artery Disease--therapy
Drug-Eluting Stents--standards
Female
Humans
Male
Percutaneous Coronary Intervention--methods
Prospective Studies
Sirolimus--administration & dosage